Learn more

SUZHOU IND PARK MICRODIAG BIOMEDICINE TECHNOLOGY CO LTD

Overview
  • Total Patents
    20
  • GoodIP Patent Rank
    124,321
About

SUZHOU IND PARK MICRODIAG BIOMEDICINE TECHNOLOGY CO LTD has a total of 20 patent applications. Its first patent ever was published in 2010. It filed its patents most often in China. Its main competitors in its focus markets biotechnology and measurement are CHENGDU TECBOND BIOLOG PRODUCTS CO LTD, WALFISH PAUL and PACIFIC EDGE LTD.

Patent filings in countries

World map showing SUZHOU IND PARK MICRODIAG BIOMEDICINE TECHNOLOGY CO LTDs patent filings in countries
# Country Total Patents
#1 China 20

Patent filings per year

Chart showing SUZHOU IND PARK MICRODIAG BIOMEDICINE TECHNOLOGY CO LTDs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Wang Tao 20
#2 Zhang Li 8
#3 Qin Yong 7
#4 Qu Xiangyun 7
#5 Sun Aijuan 5
#6 Li Zongfei 5
#7 Li Jie 5
#8 Chen Fei 4
#9 He Linfu 3
#10 Zhou Xiaojin 2

Latest patents

Publication Filing date Title
CN105274100A Human TWIST1/Vimentin gene methylation detection marker and kit
CN105112529A Human NDRG4/TFPI2 gene methylation detection marker and reagent kit
CN104774962A Kit for detecting BRAF gene mutation and detecting method thereof
CN104805206A Kit for detecting TERT (telomerase reverse transcriptase) gene promoter mutation, and detection method of kit
CN104805207A Kit for detecting kras gene mutation, and detection method of kit
CN104774963A Kit for detecting PIK3CA gene mutation and detecting method thereof
CN104762408A Kit for detecting EGFR gene mutation and detection method thereof
CN103966351A Application of CST1mRNA and CST4mRNA or proteins encoded by CST4mRNA in preparing renal cancer markers and kit of markers
CN103966350A Application of CST1mRNA (Cystatin 1 Messenger RNA) and CST4mRNA (Cystatin 4 Messenger RNA) or proteins coded by CST1mRNA and CST4mRNA in preparation of urethral carcinoma markers and kit thereof
CN104131071A Gene methylation detection method
CN104131070A Gene methylation detection method
CN104808001A Time-resolved fluorescence immunoassay method of content of sH2a in serum, and detection kit thereof
CN103721245A Application of thymosin preparation to preparation of reagent for inverting tumor-related gene mutation
CN103675300A Application of RBX1 as serum marker and reagent kit thereof
CN103397102A Detection method for quantifying gene mutation abundance
CN102861381A Table type electronic moxibustion therapeutic apparatus
CN102808027A EGFR (epidermal growth factor receptor) gene mutation site detection kit
CN101985651A New molecular marker for diagnosis and prediction of gastrointestinal tumor